Partner Mauricio Uribe featured in Medtech Innovation’s Q&A “Why NDAs are still relevant to medtech firms and start-ups"
Partner Mauricio Uribe was interviewed by Medtech Innovation for their Q&A series on “Why NDAs are still relevant to medtech firms and start-ups".
For the Q&A, Uribe discussed the effects that NDAs have on medtech inventions, the potential barriers they can create for start-ups and other important information to know, particularly in the USA.
